Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

Viatris

Status: Completed

Conditions: Affective Psychosis, Bipolar; Mania; Manic-Depressive Psychosis

Treatments: Drug: ziprasidone

Study type: Observational

Funder types: Industry

Identifiers

NCT00454883

A1281159

Details and patient eligibility

About

Assessment of ziprasidone safety and efficacy in the treatment of bipolar and schizoaffective disorders.

Full description

Method: Consecutive patient sampling. Patients were included in the study in consecutive manner if they fulfilled the inclusion criteria and any of the exclusion criteria were not present.

Enrollment: 379 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Manic and mixed episodes of up to moderate severity in patients with Type I and II bipolar disorder and schizoaffective disorder; either first diagnosed or repeated episodes

Exclusion criteria

• Hypersensitivity to ziprasidone
• prolonged QTc interval
• coadministration with substances that are prolonging the QTc interval
• recent acute MI, cardiac failure, patients with arrhythmias treated with class IA or III medicaments

Trial design

379 participants in 1 patient group

1 cohort of patients treated with ziprasidone

Treatment:

Drug: ziprasidone